Stockreport

Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock? [Yahoo! Finance]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF The company said it was in active discussion with Novo Nordisk to bring back Wegovy to its platform. The stock looks attractively priced at current levels, given its [Read more]